Abstract
Medical treatment with various cytokines can provoke psychiatric symptoms. Conversely, psychiatric patients can display abnormalities in cytokine and neurotrophic factor expression. Such observations have pointed to the potential contribution of cytokines and growth factors to schizophrenic pathology and/or etiology. The cellular targets of the relevant factors and the nature of their actions remain to be explored in mental illness, however. Recent physiological studies demonstrate that cytokines and neurotrophic factors can markedly influence synaptic transmission and plasticity upon acute or chronic application. Moreover, many of the molecular alterations observed in the schizophrenic brain are consistent with abnormalities in cytokine and neurotrophic factor regulation of these molecules. In this review, we summarize these molecular pathology findings for schizophrenia and highlight the neurodevelopmental activities of cytokines and neurotrophic factors that may contribute to the etiology or pathology of this illness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Karayiorgou M, Gogos JA . A turning point in schizophrenia genetics Neuron 1997; 19: 967–979
Gottesman II, Shields JA . Critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives Schizophr Bull 1976; 2: 360–401
Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, Mors O, et al. Effects of family history and place and season of birth on the risk of schizophrenia N Engl J Med 1999; 340: 603–608
McNeil TF . Perinatal risk factors and schizophrenia: selective review and methodological concerns Epidemiol Rev 1995; 17: 107–112
O'Callaghan E, Sham P, Takei N, Glover G, Murray RM . Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic Lancet 1991; 337: 1248–1250
Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D et al. Schizophrenia after prenatal famine. Further evidence Arch Gen Psychiatry 1996; 53: 25–31
Pulver AE, Sawyer JW, Childs B . The association between season of birth and the risk for schizophrenia Am J Epidemiol 1981; 114: 735–749
Weinberger DR . Implication of normal brain development for the pathogenesis of schizophrenia Arch Gen Psychiatry 1987; 44: 660–669
Waddington JL . Schizophrenia: developmental neuroscience and pathobiology Lancet 1993; 341: 531–536
Bogerts B . Recent advances in the neuropathology of schizophrenia Schizophr Bull 1993; 19: 431–445
Weinberger DR . From neuropathology to neurodevelopment Lancet 1995; 346: 552–557
Muller N, Ackenheil M . Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry 1998; 22: 1–33
Miyan JA, Broome CS, Afan AM . Coordinated host defense through an integration of the neural, immune and haemopoietic systems Domest Anim Endocrinol 1998; 15: 297–304
Malek-Ahmadi P . Neuropsychiatric aspects of cytokines research: an overview Neurosci Biobehav Rev 1996; 20: 359–365
Akbarian S, Bunney WE Jr, Potkin SG, Wigal SB, Hagman JO, Sandman CA et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development Arch Gen Psychiatry 1993; 50: 169–177
Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE Jr, Jones EG . Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalocortical development Arch Gen Psychiatry 1993; 50: 178–187
Benes FM . Neurobiological investigations in cingulate cortex of schizophrenic brain Schizophr Bull 1993; 19: 537–549
Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR . Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect Am J Psychiatry 1988; 145: 154–163
Conrad AJ, Scheibel AB . Schizophrenia and the hippocampus: the embryological hypothesis extended Schizophr Bull 1987; 13: 577–587
Jakob H, Beckmann H . Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects J Neural Transm Gen Sect 1994; 98: 83–106
Roberts GW . Schizophrenia: the cellular biology of a functional psychosis Trends Neurosci 1990; 13: 207–211
Harrison PJ . The neuropathology of schizophrenia. A critical review of the data and their interpretation Brain 1999; 122: 593–624
Duncan GE, Sheitman BB, Lieberman JA . An integrated view of pathophysiological models of schizophrenia Brain Res Rev 1999; 29: 250–264
Weinberger DR . Cell biology of the hippocampal formation in schizophrenia Biol Psychiatry 1999; 45: 395–402
Ross CA, Pearlson GD . Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach Trends Neurosci 1996; 19: 171–176
Jones P, Murray RM . The genetics of schizophrenia is the genetics of neurodevelopment Br J Psychiatry 1991; 158: 615–623
Eastwood SL, Burnet PW, Harrison PJ . Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia Neuroscience 1995; 66: 309–319
Eastwood SL, Harrison PJ . Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography Neuroscience 1995; 69: 339–343
Glantz LA, Lewis DA . Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity Arch Gen Psychiatry 1997; 54: 660–669
Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL . Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia Proc Natl Acad Sci USA 1996; 93: 14182–14187
Gabriel SM, Haroutunian V, Powchik P, Honer WG, Davidson M, Davies P et al. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia Arch Gen Psychiatry 1997; 54: 559–566
Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R . Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics Biol Psychiatry 1993; 34: 529–535
Stevens JR . Abnormal reinnervation as a basis for schizophrenia: a hypothesis Arch Gen Psychiatry 1992; 49: 238–243
Anderson SA, Volk DW, Lewis DA . Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects Schizophr Res 1996; 19: 111–119
Arnold SE, Lee VM, Gur RE, Trojanowski JQ . Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia Proc Natl Acad Sci USA 1991; 88: 10850–10854
Barbeau D, Liang JJ, Robitalille Y, Quirion R, Srivastava LK . Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains Proc Natl Acad Sci USA 1995; 92: 2785–2789
Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner J et al. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia Neuroscience 1997; 78: 99–110
Luthl A, Laurent JP, Figurov A, Muller D, Schachner M . Hippocampal long-term potentiation and neural cell adhesion molecules L1 and NCAM Nature 1994; 372: 777–779
Hoffman KB . The relationship between adhesion molecules and neuronal plasticity Cell Mol Neurobiol 1998; 18: 461–475
Glenthoj BY, Hemmingsen R . Transmitter dysfunction during the process of schizophrenia Acta Psychiatr Scand Suppl 1999; 395: 105–112
Nemeroff CB, Youngblood WW, Manberg PJ, Prange AJ Jr, Kizer JS . Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia Science 1983; 221: 972–975
Ferrier IN, Roberts GW, Crow TJ, Johnstone EC, Owens DG, Lee YC et al. Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia Life Sci 1983; 33: 475–482
Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ . Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia Mol Brain Res 1995; 29: 211–223
Eastwood SL, Burnet PW, Harrison PJ . GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase polymerase chain reaction (RT-PCR) study Mol Brain Res 1997; 44: 92–98
Harrison PJ, McLaughlin D, Kerwin RW . Decreased hippocampal expression of a glutamate receptor gene in schizophrenia Lancet 1991; 337: 450–452
Porter RH, Eastwood SL, Harrison PJ . Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia Brain Res 1997; 751: 217–231
Eastwood SL, Kerwin RW, Harrison PJ . Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia Biol Psychiatry 1997; 41: 636–643
Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP . Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics J Neurosci 1992; 12: 924–929
Benes FM, Vincent SL, Marie A, Khan Y . Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects Neuroscience 1996; 75: 1021–1031
Hanada S, Mita T, Nishino N, Tanaka C . [3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics Life Sci 1987; 40: 259–266
Sokolov BP . Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of ‘neuroleptic-free’ schizophrenics: evidence on reversible up-regulation by typical neuroleptics J Neurochem 1998; 71: 2454–2464
Croll SD, Wiegand SJ, Anderson KD, Lindsay RM, Nawa H . Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF Eur J Neurosci 1994; 6: 1343–1353
Mizuno K, Carnahan J, Nawa H . Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons Dev Biol 1994; 165: 243–256
Nawa H, Bessho Y, Carnahan J, Nakanishi S, Mizuno K . Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor J Neurochem 1993; 60: 772–775
Nawa H, Pelleymounter MA, Carnahan J . Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain J Neurosci 1994; 14: 3751–3765
Nawa H, Carnahan J, Gall C . BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels Eur J Neurosci 1995; 7: 1527–1535
Narisawa-Saito M, Carnahan J, Araki K, Yamaguchi T, Nawa H . Brain-derived neurotrophic factor regulates the expression of AMPA receptor proteins in neocortical neurons Neuroscience 1999; 88: 1009–1014
Narisawa-Saito M, Silva AJ, Yamaguchi T, Hayashi T, Yamamoto T, Nawa H . Growth factor-mediated fyn signaling regulates AMPA receptor expression in rodent neocortical neurons Proc Natl Acad Sci USA 1999; 96: 2461–2466
Xiong H, Yamada K, Han D, Nabeshima T, Enikolopov G, Carnahan J et al. Mutual regulation between the intercellular messengers nitric oxide and brain-derived neurotrophic factor in rodent neocortical neurons Eur J Neurosci 1999; 11: 1567–1576
Maffei L, Berardi N, Domenici L, Parisi V, Pizzorusso T . Nerve growth factor (NGF) prevents the shift in ocular dominance distribution of visual cortical neurons in monocularly deprived rats J Neurosci 1992; 12: 4651–4662
Cabelli RJ, Hohn A, Shatz CJ . Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF Science 1995; 267: 1662–1666
McAllister AK, Lo DC, Katz LC . Neurotrophins regulate dendritic growth in developing visual cortex Neuron 1995; 15: 791–803
Prakash N, Cohen-Cory S, Frostig RD . RAPID and opposite effects of BDNF and NGF on the functional organization of the adult cortex in vivo Nature 1996; 381: 702–706
Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE Jr, Jones EG . Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients Arch Gen Psychiatry 1996; 53: 425–436
Chun JJ, Nakamura MJ, Shatz CJ . Transient cells of the developing mammalian telencephalon are peptide-immunoreactive neurons Nature 1987; 325: 617–620
Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics Arch Gen Psychiatry 1995; 52: 258–266
Tueting P, Costa E, Dwivedi Y, Guidotti A, Impagnatiello F, Manev R et al. The phenotypic characteristics of heterozygous reeler mouse Neuroreport 1999; 10: 1329–1334
Ringstedt T, Linnarsson S, Wagner J, Lendahl U, Kokaia Z, Arenas E et al. BDNF regulates reelin expression and Cajal–Retzius cell development in the cerebral cortex Neuron 1998; 21: 305–315
Ringstedt T, Linnarsson S, Wagner J, Lendahl U, Kokaia Z, Arenas E et al. BDNF regulates reelin expression and Cajal–Retzius cell development in the cerebral cortex Neuron 1998; 21: 305–315
Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia Proc Natl Acad Sci USA 1998; 22: 15718–15723
Sasaki T, Dai XY, Kuwata S, Fukuda R, Kunugi H, Hattori M et al. Brain-derived neurotrophic factor gene schizophrenia in Japanese subjects Am J Med Genet 1997; 74: 443–444
Khan AS, Freedman R, Byerley W, Leonard S . Temperature gradient gel electrophoresis analysis of the beta-NGF gene in schizophrenia J Psychiatry Neurosci 1995; 20: 199–209
Nanko S, Hattori M, Kuwata S, Sasaki T, Fukuda R, Dai XY et al. Neurotrophin-3 gene polymorphism associated with schizophrenia Acta Psychiatr Scand 1994; 89: 390–392
Thome J, Kornhuber J, Baumer A, Rosler M, Beckmann H, Riederer P . Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased incidence of psychiatric diseases? Neurosci Lett 1996; 203: 109–110
Prolo P, Licinio J . Cytokines in affective disorders and schizophrenia: new clinical and genetic findings Mol Psychiatry 1999; 4: 109–111
Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K et al. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients Mol Psychiatry 2000; 5: 293–300
Schramm M, Falkai P, Feldmann N, Knable MB, Bayer TA . Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia Neurosci Lett 1998; 257: 65–68
Toyooka K, Shirakawa O, Kitamura N, Hashimoto T, Maeda K, Wakabayashi K et al. Large individual variations in BDNF content in human brain and serum Soc Neurosci Abstr 1999; 29: 200.11
Takahashi M, Hayashi S, Kakita A, Wakabayashi K, Fukuda M, Kameyama S et al. Patients with temporal lobe epilepsy show an increase in brain-derived neurotrophic factor protein and its correlation with neuropeptide Y Brain Res 1999; 818: 579–582
Smith MA, Makino S, Kvetnansky R, Post RM . Effects of stress on neurotrophic factor expression in the rat brain Ann N Y Acad Sci 1995; 771: 234–239
Wassink TH, Nelson JJ, Crowe RR, Andreasen NC . Heritability of BDNF alleles and their effect on brain morphology in schizophrenia Am J Med Genet 1999; 88: 724–728
Arinami T, Toru M . No evidence for association between CNTF null mutant allele and schizophrenia Br J Psychiatry 1996; 169: 253
Dawson E, Powell JF, Sham PC, Nothen M, Crocq MA, Propping P et al. An association study of a neurotrophin-3 (NT-3) gene polymorphism with schizophrenia Acta Psychiatr Scand 1995; 92: 425–428
Katila H, Hanninen K, Hurme M . Polymorphisms of the interleukin-1 gene complex in schizophrenia Mol Psychiatry 1999; 4: 179–181
Patterson PH, Nawa H . Neuronal differentiation factors/cytokines and synaptic plasticity Cell 1993; 72 Suppl: 123–137
Licinio J, Wong, M-L . Pathways and mechanisms for cytokine signalling of the central nervous system J Clin Invest 1997; 100: 2941–2947
Stoop R, Poo MM . Synaptic modulation by neurotrophic factors Prog Brain Res 1996; 109: 359–364
Schuman EM . Neurotrophin regulation of synaptic transmission Curr Opin Neurobiol 1999; 9: 105–109
Jankowsky JL, Patterson PH . Cytokine and growth factor involvement in long term potentiation Mol Cell Neurosci 1999; 14: 273–286
Nitta T . Cytokine gene expression within the central nervous system Cell Mol Neurobiol 1998; 18: 703–708
Jankowsky JL, Patterson PH . The role of cytokines and growth factors in seizure and its sequelae Progr Neurobiol 2000 (in press
Yates WR, Gleason O . Hepatitis C and depression Depress Anxiety 1998; 7: 188–193
Pavol MA, Meyers CA, Rexer JL, Valentine AD, Mattis PJ, Talpaz M . Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia Neurology 1995; 45: 947–950
Licinio J, Wong M-L . The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection Mol Psychiatry 1999; 4: 317–327
Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells Ann Intern Med 1987; 107: 293–300
Rafalowska J . HIV-1-infection in the CNS. A pathogenesis of some neurological syndromes in the light of recent investigations Folia Neuropathol 1998; 36: 211–216
Lapchak PA, Araujo DM, Hefti F . Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation Neuroscience 1993; 53: 297–301
Xiong H, Narisawa-Saito M, Jourdi H, Takei N, Nawa H . The glutamate receptor-mediated regulation of brain-derived neurotrophic factor production by cytokines in central nervous system Soc Neurosci Abstr 1999; 25: 407.10
Lindholm D, Heumann R, Meyer M, Thoenen H . Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve Nature 1987; 330: 658–659
Heese K, Hock C, Otten U . Inflammatory signals induce neurotrophin expression in human microglial cells J Neurochem 1998; 70: 699–707
Fatemi SH, Emamian ES, Kist D, Sidwell RW, Nakajima K, Akhter P et al. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice Mol Psychiatry 1999; 4: 145–154
Davis KL, Kahn RS, Ko G, Davidson M . Dopamine in schizophrenia: a review and reconceptualization Am J Psychiatry 1991; 148: 1474–1486
Toru M, Kurumaji A, Ishimaru M . Excitatory amino acids: implications for psychiatric disorders research Life Sci 1994; 55: 1683–1699
Rutherford LC, Nelson SB, Turrigiano GG . BDNF has opposite effects on the quantal amplitude of pyramidal neuron and interneuron excitatory synapses Neuron 1998; 21: 521–530
Hyman C, Juhasz M, Jackson C, Wright P, Ip NY, Lindsay RM . Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon J Neurosci 1994; 14: 335–347
Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ et al. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo Proc Natl Acad Sci USA 1992; 89: 11347–11351
Du X, Stull ND, Iacovitti L . Brain-derived neurotrophic factor works coordinately with partner molecules to initiate tyrosine hydroxylase expression in striatal neurons Brain Res 1995; 680: 229–233
Lipton SA, Kater SB . Neurotransmitter regulation of neuronal outgrowth, plasticity and survival Trends Neurosci 1989; 12: 265–270
Mattson MP, Lee RE, Adams ME, Guthrie PB, Kater SB . Interactions between entorhinal axons and target hippocampal neurons: a role for glutamate in the development of hippocampal circuitry Neuron 1988; 1: 865–876
McDonald JW, Johnston, MV . Physiological and pathophysiological roles of excitatory amino acids during central nervous system development Brain Res Rev 1990; 15: 41–70
Otmakhova NA, Lisman JE . D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses J Neurosci 1996; 16: 7478–7486
Zhu H, Wu F, Schacher S . Site-specific and sensory neuron-dependent increases in postsynaptic glutamate sensitivity accompany serotonin-induced long-term facilitation at Aplysia sensorimotor synapses J Neurosci 1997; 17: 4976–4986
Poltorak M, Wright R, Hemperly JJ, Torrey EF, Issa F, Wyatt RJ et al. Monozygotic twins discordant for schizophrenia are discordant for N-CAM and L1 in CSF Brain Res 1997; 751: 152–154
Cotter D, Kerwin R, Doshi B, Martin CS, Everall IP . Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia Brain Res 1997; 765: 238–246
Virgo L, Humphries C, Mortimer A, Barnes T, Hirsch S, de Belleroche J . Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia Biol Psychiatry 1995; 37: 694–701
Breese CR, Freedman R, Leonard SS . Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers Brain Res 1995; 674: 82–90
Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics J Neurosci 1996; 16: 19–30
Huntsman MM, Tran BV, Potkin SG, Bunney WE Jr, Jones EG . Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics Proc Natl Acad Sci USA 1998; 95: 15066–15071
Harrington KA, Augood SJ, Faull RL, McKenna PJ, Emson PC . Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridisation study Mol Brain Res 1995; 33: 333–342
Schmauss C, Haroutunian V, Davis KL, Davidson M . Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia Proc Natl Acad Sci USA 1993; 90: 8942–8946
Schmauss C . Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia J Neurosci 1996; 16: 7902–7909
Mulcrone J, Kerwin RW . No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenics Neurosci Lett 1996; 219: 163–166
Roberts DA, Balderson D, Pickering-Brown SM, Deakin JF, Owen F . The relative abundance of dopamine D4 receptor mRNA in post mortem brains of schizophrenics and controls Schizophr Res 1996; 20: 171–174
Stefanis NC, Bresnick JN, Kerwin RW, Schofield WN, McAllister G . Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain Mol Brain Res 1998; 53: 112–119
Burnet PW, Eastwood SL, Harrison PJ . 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia Neuropsychopharmacology 1996; 15: 442–455
Hefti F, Hartikka J, Eckenstein F, Gnahn H, Heumann R, Schwab M . Nerve growth factor increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons Neuroscience 1985; 14: 55–68
Marty S, Carroll P, Cellerino A, Castren E, Staiger V, Thoenen H et al. Brain-derived neurotrophic factor promotes the differentiation of various hippocampal nonpyramidal neurons, including Cajal–Retzius cells, in organotypic slice cultures J Neurosci 1996; 16: 675–687
Pappas IS, Parnavelas JG . Neurotrophins and basic fibroblast growth factor induce the differentiation of calbindin-containing neurons in the cerebral cortex Exp Neurol 1997; 144: 302–314
Xiong H, Yamada K, Han D, Nabeshima T, Enikolopov G, Carnahan J et al. Mutual regulation between the intercellular messengers nitric oxide and brain-derived neurotrophic factor in rodent neocortical neurons Eur J Neurosci 1999; 11: 1567–1576
Narisawa-Saito M, Carnahan J, Araki K, Yamaguchi T, Nawa H . Brain-derived neurotrophic factor regulates the expression of AMPA receptor proteins in neocortical neurons Neuroscience 1999; 88: 1009–1014
Zhou J, Bradford HF, Stern GM . Induction of dopaminergic neurotransmitter phenotype in rat embryonic cerebrocortex by the synergistic action of neurotrophins and dopamine Eur J Neurosci 1996; 8: 2328–2339
Takei N, Sasaoka K, Inoue K, Takahashi M, Endo Y, Hatanaka H . Brain-derived neurotrophic factor increases the stimulation-evoked release of glutamate and the levels of exocytosis-associated proteins in cultured cortical neurons from embryonic rats J Neurochem 1997; 68: 370–375
Galter D, Unsicker K . Regulation of the transmitter phenotype of rostral and caudal groups of cultured serotonergic raphe neurons Neuroscience 1999; 88: 549–559
Ozaki M, Sasner M, Yano R, Lu HS, Buonanno A . Neuregulin-beta induces expression of an NMDA-receptor subunit Nature 1997; 390: 691–694
Cheng B, Furukawa K, O'Keefe JA, Goodman Y, Kihiko M, Fabian T . Basic fibroblast growth factor selectively increases AMPA-receptor subunit GluR1 protein level and differentially modulates Ca2+ responses to AMPA and NMDA in hippocampal neurons J Neurochem 1995; 65: 2525–2536
Lapchak PA, Miller PJ, Jiao S . Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats Neuroscience 1997; 77: 745–752
Scarborough DE, Lee SL, Dinarello CA, Reichlin S . Interleukin-1 beta stimulates somatostatin biosynthesis in primary cultures of fetal rat brain Endocrinology 1989; 124: 549–551
Ling ZD, Potter ED, Lipton JW, Carvey PM . Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines Exp Neurol 1998; 149: 411–423
Kamegai M, Niijima K, Kunishita T, Nishizawa M, Ogawa M, Araki M et al. Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo Neuron 1990; 4: 429–436
Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H . Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures Neuroscience 1991; 40: 445–452
Rudge JS, Eaton MJ, Mather P, Lindsay RM, Whittemore SR . CNTF induces raphe neuronal precursors to switch from a serotonergic to a cholinergic phenotype in vitro Mol Cell Neurosci 1996; 7: 204–221
Marz P, Heese K, Dimitriades-Schmutz B, Rose-John S, Otten U . Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression Glia 1999; 26: 191–200
Blesch A, Uy HS, Grill RJ, Cheng JG, Patterson PH, Tuszynski MH . Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury J Neurosci 1999; 19: 3556–3566
Alheim K, Andersson C, Tingsborg S, Ziolkowska M, Schultzberg M, Bartfai T . Interleukin 1 expression is inducible by nerve growth factor in PC12 pheochromocytoma cells Proc Natl Acad Sci USA 1991; 88: 9302–9306
Acknowledgements
We thank Dr Someya for comments on this manuscript. Work cited from the authors’ laboratories was supported by the Japanese Society for the Promotion of Science (RFTF-96L00203) (HN), Grant-in-Aid for Scientific Research (MESSC) (HN), the National Institute of Neurological Disease and Stroke and the National Alliance for Research on Schizophrenia and Depression (PHP).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nawa, H., Takahashi, M. & Patterson, P. Cytokine and growth factor involvement in schizophrenia—support for the developmental model. Mol Psychiatry 5, 594–603 (2000). https://doi.org/10.1038/sj.mp.4000730
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000730
Keywords
This article is cited by
-
Perinatal complications and executive dysfunction in early-onset schizophrenia
BMC Psychiatry (2020)
-
Decreased Serum EGF in First-episode and Chronic Schizophrenia Patients: Negative Correlation with Psychopathology
Scientific Reports (2020)
-
Effects of prenatal Poly I:C exposure on global histone deacetylase (HDAC) and DNA methyltransferase (DNMT) activity in the mouse brain
Molecular Biology Reports (2016)
-
An Association Between Functional Polymorphisms of the Interleukin 1 Gene Complex and Schizophrenia Using Transmission Disequilibrium Test
Archivum Immunologiae et Therapiae Experimentalis (2016)
-
Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice
Molecular Psychiatry (2012)